Investment Summary

SHS Capital Invests In TRI

On September 3, 2014, private equity firm SHS Capital invested in medical products company TRI

Investment Highlights
  • This is SHS Capital’s 5th transaction in the Medical Products sector.
  • This is SHS Capital’s 1st transaction in Switzerland.

Investment Summary

Date 2014-09-03
Target TRI
Sector Medical Products
Investor(s) SHS Capital
Deal Type Growth Capital

Target

TRI

Hunenberg, Switzerland
TRI is a dental implants manufacturer that offers a digital portfolio and is additionally developing a Digital-Implant which integrates the dental implant connection specifically designed for CAD/CAM and 3D-printed prosthetics and thus allows for the connection of a ceramic crown directly to the implant, eliminating the need for an abutment. TRI was founded in 2010 and is based in Hunenberg, Switzerland.

Search 214,239 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Investor(S) 1

Investor
DESCRIPTION

SHS Capital is a private equity firm focused on the healthcare sector. Specific areas of interest include life science, medical technology, diagnostics, applied technologies, digital health, and industrial biotechnology. The Firm will consider opportunities at all company stages and looks to commit up to €50 million in businesses valued up to €150 million. Target geographies include Germany, Austria, Switzerland, Scandinavia, and Benelux. SHS Capital was established in 1993 and is headquartered in Tubingen, Germany.


DEAL STATS #
Overall 11 of 35
Sector: Medical Products M&A 5 of 19
Type: Growth Capital M&A Deals 7 of 21
Country: Switzerland M&A 1 of 7
Year: 2014 M&A 1 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2011-09-14 Miracor Medical

Awans, Belgium

Miracor Medical is an operator of MedTech that is developing and commercializing a unique and potentially disruptive therapy for patients with impaired cardiac function. Miracor Medical was founded in 2008 and is based in Awans, Belgium.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2014-09-08 AMW

Warngau, Germany

AMW is a specialty pharmaceutical company that develops and manufactures active and passive transdermal patches, biodegradable subcutaneous implants, and intravaginal rings, by using its patented and proprietary technologies. AMW was founded in 2008 and is based in Warngau, Germany.

Buy -